H.R. 4494 — A bill to launch a national strategy to support regenerative medicine through funding for research and commercial development of regenerative medicine products and development of a regulatory environment that enables rapid approval of safe and effective products, and for other purposes; to the Committee on Energy and Commerce.
By Ms. DeGETTE (for herself and Mr. Paulsen), H3240 [28AP]